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SUMMARY
Mononuclear phagocytes, including monocytes, macrophages and dendritic cells, contribute to
tissue integrity, as well as innate and adaptive immune defense. Emerging evidence for labour
division indicates that manipulation of these cells could bear therapeutic potential. However,
specific ontogenies of individual populations and the overall functional organisation of the cellular
network are not well-defined. Here we report a fate mapping study of the murine monocyte and
macrophage compartment taking advantage of constitutive and conditional CX3CR1 promoter-
driven Cre recombinase expression. We have demonstrated that major tissue resident macrophage
populations, including liver Kupffer cells, lung alveolar, splenic and peritoneal macrophages, are
established prior to birth and maintain themselves subsequently during adulthood independent of
replenishment by blood monocytes. Furthermore, we have established that the short-lived Ly6C+
monocytes constitute obligatory steady state precursors of blood-resident Ly6C− cells and that the
abundance of Ly6C+ blood monocytes dynamically controls the circulation life span of their
progeny.
INTRODUCTION
The mononuclear phagocyte system (van Furth et al., 1972) today comprises monocytes,
macrophages and dendritic cells (DCs), as well as their respective committed bone marrow
(BM) - resident progenitors (Geissmann et al., 2010). Collectively, these cells play central
roles in the maintenance of tissue integrity during development and its restoration after
injury, as well as the initiation and resolution of innate and adaptive immunity.
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Historically, mononuclear phagocyte subpopulations have been defined according to
anatomic location and surface marker profiles. More recently, this definition has been
extended to comprise dependence of subpopulations on specific growth and transcription
factors (Hashimoto et al., 2011; Lawrence and Natoli, 2011), subset-specific gene
expression signatures (Robbins et al., 2008) and distinct ontogenies (Geissmann et al.,
2010).
A major breakthrough in defining mononuclear phagocyte development in the adult
organism was the identification of a clonotypic BM-resident founder cell, termed
Macrophage-DC precursor (MDP), that gives rise to peripheral mononuclear phagocytes
while having lost granulocyte potential (Fogg et al., 2006). MDPs differentiate within the
BM into monocytes (Varol et al., 2007) and dedicated DC precursors, the preDCs (Liu et al.,
2009). Both these cell types are subsequently released into the circulation to allow
repopulation of peripheral tissue macrophages and classical Fms-like tyrosine kinase 3
ligand (Flt3L) -dependent DCs, respectively. The MDP-preDC route is critical to ensure the
constant replenishment of the ephemeral DC compartment. The relative importance of local
proliferation versus recruitment from monocytes in the maintenance of tissue macrophage
homeostasis has been debated since the original definition of the mononuclear phagocyte
system ((Hume, 2006; Hume et al., 2002). The original studies of Kupffer cell turnover in
the liver, for example, concluded that very few resident MΦ's are actively in cycle (Crofton
et al., 1978). This proliferation is ablated by glucocorticoids, which also removes blood
monocytes. The authors concluded, that the proliferating cells were monocytederived. That
conclusion was however undermined by later evidence that glucocorticoids oppose growth
factor activity, including the macrophage growth factor, CSF-1 (Hume and Gordon, 1984).
In certain situations, such as helminth-associated T helper-2 cell milieus, expansion of local
macrophages can rely solely on proliferation of tissue-resident macrophages exclusive of
monocyte influx (Jenkins et al., 2011). Under inflammatory conditions resident
macrophages are complemented by recruited monocytes that differentiate in situ into
macrophages. However, when analyzed the contribution of these infiltrating cells was found
to be transient (Ajami et al., 2011; Leuschner et al., 2012), while resident macrophages bring
about the resolution of the inflammatory response and restore macrophage homeostasis
(Davies et al., 2011).
Myeloid cells, including mononuclear phagocytes, are known to arise from two successive
hematopoetic waves, referred to as 'primitive' and 'definitive', respectively (Orkin and Zon,
2008). As best exemplified for the brain microglia (Alliot et al., 1999; Ginhoux et al., 2010),
mononuclear phagocytes can be generated during development from primitive macrophages
generated in the yolk sac, an extra-embryonic tissue. Once established, microglia cells
maintain themselves throughout adult life by virtue of longevity and limited self-renewal
without input from definitive hematopoesis (Ajami et al., 2007; Ginhoux et al., 2010;
Mildner et al., 2007). Geissmann and coworkers recently provided evidence of the existence
of a macrophage lineage lineage that is independent of the transcription factor myb (Schulz
et al., 2012). In addition to microglia, autonomy from definitive hematopoesis was shown
for F4/80bright CD11bint tissue macrophage populations, including Kupffer and Langerhans’
cells.
The chemokine receptor CX3CR1 is widely expressed in the mononuclear phagocyte
system. Indeed, mice harbouring a GFP reporter in the CX3CR1 locus (Jung et al., 2000)
have been instrumental in identifying and defining MDPs (Fogg et al., 2006), pre-DCs (Liu
et al., 2009), as well as tissue-resident mononuclear phagocyte populations (Bar-On et al.;
Lewis et al., 2011; Niess et al., 2005; Varol et al., 2009). Moreover, discrete expression of
CX3CR1/GFP in Cx3cr1gfp animals led to the identification of two monocyte subsets in
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mice, characterized as CX3CR1int Ly6C+ and CX3CR1hi Ly6C− cells ((Geissmann et al.,
2003; Palframan et al., 2001), corroborating earlier studies on human blood (Passlick et al.,
1989). CX3CR1int Ly6C+ monocytes are the correlate of human CD14+ CD16+ and CD14+
CD16− monocytes (Cros et al., 2010) and poised to traffic to sites of infection and
inflammation (Geissmann et al., 2003; Serbina et al., 2008). CX3CR1hi Ly6C−’patrolling’
monocytes – the correlate of human CD14dim CD16+ cells (Cros et al., 2010) - have been
shown to adhere and crawl along the luminal surface of endothelial cells (Auffray et al.,
2007). In absence of inflammation CX3CR1int Ly6C+ monocytes can return to the BM and
differentiate into CX3CR1hi Ly6C− cells (Varol et al., 2007). However, it is unclear whether
the generation of CX3CR1hi Ly6C− monocytes requires CX3CR1int Ly6C+ monocytes as
obligatory intermediate or whether CX3CR1hi Ly6C− monocytes can - like CX3CR1int
Ly6C+ monocytes (Varol et al., 2007) - also originate directly from MDPs. Moreover, if
alternative pathways exist their relative contribution to the steady state generation of
monocytes remains unclear.
Here, report a fate mapping study of the murine mononuclear phagocyte compartment using
mice that harbour genes encoding conditional or constitutive active Cre recombinase in their
CX3CR1 loci. We have demonstrated that tissue resident macrophage populations, including
peritoneal, splenic and lung macrophages, as well as liver Kupffer cells, are established prior
to birth and in adult steady state disconnected from monocyte input. Side-by-side
comparison of Cx3cr1cre and Cx3cr1creER mice crossed to reporter animals, as well as
Cx3cr1gfp mice, combined with bromodeoxyuridine (BrdU) pulsing experiments, adoptive
transfers and the analysis of Ccr2-deficient mixed BM chimeras, provided critical insights
into monocyte dynamics. Specifically, we have established that CX3CR1int Ly6C+
monocytes form in steady state a short-lived obligatory precursor intermediate for the
generation of Ly6C− monocytes and, presumably as CSF-1 sink, dynamically control the life
span of their progeny.
RESULTS
Dual origins of resident macrophages
To exploit the pronounced activity of the CX3CR1 promoter in the mononuclear phagocyte
system for its study, we manipulated the murine CX3CR1 loci to harbour Cre recombinase
genes. Specifically, we replaced the Cx3cr1 gene with genes encoding either cre
recombinase or a cre recombinase fusion to a mutant estrogen ligand-binding domain that
requires the presence of the estrogen antagonist tamoxifen for activity (CreERT2) (Metzger
et al., 1995), yielding Cx3cr1cre and Cx3cr1creER mice (Fig. 1A).
Recent studies have highlighted the differential origins of discrete peripheral macrophage
and DC compartments in adult mice (Geissmann et al., 2010). Given the broad expression of
the Cx3cr1 gene within the mononuclear phagocyte system we decided to perform a side-by-
side comparison of the reporter gene activation patterns in Cx3cr1gfp, Cx3cr1cre and
Cx3cr1creER mice, the latter crossed to R26-yfp reporter animals (Srinivas et al., 2001)
(Supplemental Fig. 1). Macrophage populations from Cx3cr1gfp and Cx3cr1cre:R26-yfp mice
fell into two categories. Cells, such as microglia, intestinal and renal macrophages express
the CX3CR1 chemokine receptor (Jung et al., 2000; Niess et al., 2005; Soos et al., 2006)
hence found labelled in both Cx3cr1gfp and Cx3cr1cre:R26-yfp mice (Fig. 1B). A second
group of cells ceased to express the chemokine receptor but obviously originated from
CX3CR1+ precursors, indicated by an absence and presence of label in Cx3cr1gfp and
Cx3cr1cre:R26-yfp mice, respectively. This included peritoneal macrophages, liver Kupffer
cells, splenic and lung macrophages as well as epidermal Langerhans’ cells (Fig. 1C).
Coexistence of the respective CX3CR1-positive cells and CX3CR1-negative cells that
acquired the label during their past in steady state tissues was confirmed by the histological
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examination of triple transgenic Cx3cr1gfp:Cx3cr1cre:R26-rfp mice, which harboured
differentially labelled cells, as exemplified for RFP-positive CD11bint F4/80hi Kupffer cells
and GFP-positive CD11bhi F4/80int perivascular macrophage’s in the liver (Fig. 2A i).
Moreover, the notion that CX3CR1-negative CD11bint F4/80hi Kupffer cells derive from
cells that previously expressed CX3CR1 was corroborated by the fact that CD11bint F4/80hi
Kupffer cells were found to be GFP+ in fetal livers, but GFP− in adult livers of Cx3cr1gfp
mice (Fig. 2Aii). Since in Cx3cr1cre:R26-yfp mice Cre recombinase is constitutively active,
the CX3CR1+ precursors establishing the label of CX3CR1-negative tissue macrophages
could be associated with prenatal development, or represent adult precursors, such as MDPs
or monocytes (Fogg et al., 2006; Jung et al., 2000). To distinguish between these two
scenarios, we took advantage of Cx3cr1creER:R26-yfp mice, in which Cre activity can be
regulated by drug administration and hence induced after birth. One month of continuous
tamoxifen exposure of adult animals resulted in the efficient reporter gene expression in
CX3CR1+ resident macrophages and microglia of Cx3cr1creER:R26-yfp mice (Fig. 1B).
Moreover, it yielded substantial excision of the LoxP-flanked STOP cassette from the R26-
STOP-YFP loci, and hence YFP expression, in the monocyte compartment (see below).
However, no reporter gene expression was detected in the CX3CR1− macrophage
populations of the tamoxifen-treated Cx3cr1creER:R26-yfp mice signifying that no
monocytes had entered the pool.
To formally establish that descendants of monocytes from tamoxifen-treated animals can be
detectable according to reporter gene expression after an extended period of time in a tissue
context, we resorted to an adoptive transfer strategy focusing on intestinal resident
macrophages which we previously established to be Ly6C+ monocyte-derived (Varol et al.,
2009). Specifically, Ly6C+ YFP− BM monocytes isolated from tamoxifen-treated mice were
adoptively transferred into diphtheria toxin-treated [CD11c-DTR > WT] BM chimeras
(Varol et al., 2009). As seen in Fig. 2B, grafted cells gave rise to YFP+ lamina propria
macrophage’s Notably, as the recipients were not treated with tamoxifen, the rearrangement
of the R26-STOP-YFP loci must have occurred in the donor animals. The fact that
monocyte-derived cells could be detected in tamoxifentreated adult Cx3cr1creER:R26-yfp
mice according to their reporter expression was further corroborated by analysing mice
challenged intraperitoneally with thioglycollate, which led to the appearance of RFP+ cells
in the peritoneal cavities 72 hrs after treatment (Fig. 2C). Interestingly, following the
resolution of this response cells derived from the monocyte infiltrate persisted for up to two
months after challenge. This was associated with a phenotypic shift to MHC II lo F4/80hi
cells suggesting the integration of the monocyte-derived cells into the resident macrophage
pool (Fig 2C).
Collectively, the absence of label in resident CX3CR1− macrophage populations of
tamoxifen-treated Cx3cr1creER:R26-yfp mice establishes that there is no on-going steady
state contribution of monocytes to Kupffer cells or peritoneal, splenic and lung macrophages
and that these cells derive prenatally originating either independent from the yolk sac or
fetal liver cells and subsequently maintaining themselves through longevity and limited self-
renewal.
Characterization of Myeloid Precursors and Monocytes in Cx3cr1cre:R26-yfp and
Cx3cr1creER:R26-yfp mice
CX3CR1 chemokine receptor expression commences with the first dedicated mononuclear
phagocyte precursor, the MDP, and expression is subsequently maintained in DC-committed
precursors (CDPs, preDCs) and monocytes (Fogg et al., 2006; Liu et al., 2009; Onai et al.,
2007). All these cell populations are consequently homogeneously marked by reporter gene
expression in Cx3cr1gfp mice (Fig. 3A). Interestingly however, reporter gene expression was
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absent from MDPs of Cx3cr1cre:R26-yfp mice; rather YFP+ cells first appeared at the CDP
and Ly6C+ monocyte stage (Fig. 3). This delay of YFP expression compared to Cx3cr1gfp
mice may be due to the time restraint imposed by the required rearrangement for STOP
cassette excision prior to reporter gene expression in Cx3cr1cre:R26-yfp animals. In
Cx3cr1creER:R26-yfp mice, where reporter activation requires the nuclear translocation of
the CreER protein prior to rearrangement, YFP expression was found to be even further
restricted. Thus, in tamoxifen-treated Cx3cr1creER:R26-yfp mice reporter gene expression
was absent from CDPs and Ly6C+ monocytes (Fig. 3B). Only Ly6C− monocytes - and only
a fraction of them - expressed YFP even after extended tamoxifen treatment (Fig. 3B). The
differential appearance of the YFP label in Ly6C+ and Ly6C− monocyte subsets indicated
distinct temporal requirements for their creation, supporting the notion of their sequential
generation (Sunderkotter et al., 2004; Varol et al., 2007,; Yrlid et al., 2006). Notably, key
surface markers recently reported for the two monocytes subsets (Ingersoll et al., 2010),
displayed gradual alterations between Ly6C+ YFP−, Ly6C− YFP− and Ly6C− YFP+ cells in
Cx3cr1creER:R26-yfp mice (Supplemental Fig. 2A). Furthermore, comparison of expression
of these markers by Cx3cr1cre:R26-yfp monocyte subsets also demonstrated gradual changes
from Ly6C+ YFP−, to Ly6C+ YFP+ and Ly6C− YFP+ cells (Supplemental Fig. 2B). Taken
together, reporter gene expression kinetics in Cx3cr1cre and Cx3cr1creER:R26-yfp mice and
the gradual acquisition of maturation markers in the monocyte subsets support the notion
that Ly6C+ monocytes differentiate into Ly6C− monocytes in steady state.
Ly6C− monocytes derive from Ly6C+ monocytes independently in BM and blood
With the definition of MDPs as in vivo monocyte precursors (Varol et al., 2007), the
question arose whether these cells give rise to both CX3CR1int Ly6C+ and CX3CR1hi Ly6C−
monocytes or whether the two monocyte subsets are part of a developmental sequence
(Sunderkotter et al., 2004; Varol et al., 2007; Yrlid et al., 2006). While adoptively-
transferred Ly6C+ CX3CR1int monocytes isolated from BM can give rise to Ly6C−
CX3CR1hi monocytes in recipient mice (Varol et al., 2007)., these grafts could have
arguably been contaminated with immature BM precursors. To exclude this possibility, we
isolated CX3CR1GFP/+ Ly6C+ monocytes from the splenic reservoir (Swirski et al., 2009)
and grafted them into congenic WT mice (Supplemental Fig. 3A). Recipients were
sacrificed at various time points following adoptive transfer and subjected to flow cytometry
analysis. One day after transfer grafted cells were detectable in recipient blood, BM and
spleen as Ly6C+ CX3CR1/GFPint cells (Supplemental Fig. 3B). However, corroborating our
earlier study (Varol et al., 2007), by day 3 grafted splenic Ly6C+ monocytes had
quantitatively differentiated into Ly6C− CX3CR1/GFPhi cells.
Next, we compared the differentiation potential of Ly6C+ YFP− and Ly6C+ YFP+
monocytes of Cx3cr1cre:R26-yfp mice. Isolated monocyte subsets were grafted into
congenic WT recipient mice. Analysis over a three-day period revealed a number of
sequential steps required for Ly6C+ monocytes to convert. Ly6C+ YFP− monocytes
transformed from being YFP-negative to cells expressing the YFP reporter prior to
converting into Ly6C− monocytes, authenticating the notion that Ly6C+ monocytes are the
precursors of Ly6C− monocytes and our earlier assumption that acquisition of the YFP label
by monocytes is a matter of time (Supplemental Fig. 4).
To further investigate the interrelation of blood monocytes and determine their turnover
rates, we resorted to a 5-bromo-2'-deoxyuridine (BrdU) pulsing regime. Specifically, mice
were dosed with three intraperitoneal (i.p.) injections of 2 mg BrdU (3 hrs apart) and
subsequently monitored over a 5-day period for the presence of the thymidine analog in the
genome of the monocyte subsets. This low dose of BrdU is unlikely to be mitogenic
(Takizawa et al., 2011). Since only a minor subset of monocytic cells is in cell cycle, BrdU
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is expected to be incorporated into dividing monocyte precursors, such as MDPs. One day
following the first BrdU injection, all circulating Ly6C+ monocytes were BrdU-positive
(Fig. 4A). In contrast, no Ly6C− blood monocytes had incorporated label by day 1,
indicating that these cells are not recently generated from a dividing precursor. The fraction
of BrdU+ cells in the Ly6C− compartment gradually increased to around one third by day 5
(Fig. 4A), whereas the Ly6C+ monocytes lost the label by day 5. Fitting an exponential
trendline from day 2, i.e. the peak of BrdU label, to day 5, we calculated the steady state
half-live of the Ly6C+ blood monocytes to be 0.843 days (20 hrs) (r2=0.932). The sequential
acquisition of the BrdU label by the blood monocyte subsets suggested that it was
incorporated into monocyte precursors that differentiated into Ly6C+ monocytes and
subsequently moved with time to Ly6C− monocytes. To corroborate this assumption we
took advantage of a cell ablation strategy targeting Ly6C+ monocytes based on the injection
of the CCR2 antibody MC21 (Bruhl et al., 2007). MC21 treatment of BrdU-pulsed mice on
day 1 efficiently ablated CCR2+ Ly6C+ monocytes and spared as reported CCR2− Ly6C−
cells (Fig. 4B). Interesting though and supporting the notion of a precursor/product
relationship of the two monocyte subsets, removal of BrdU-labelled Ly6C+ monocytes also
prevented accumulation of the BrdU label in the Ly6C− monocyte population (Fig. 4B).
To refine our analysis and extend it to monocytes residing in BM, C57BL/6 animals were
injected with a single dose of BrdU (2 mg) (Fig. 4C). Analysis of blood monocytes
confirmed the sequential appearance of the BrdU label in Ly6C+ and Ly6C− monocytes,
respectively. Ly6C+ monocytes in the BM were labeled before Ly6C+ blood monocytes
consistent with their generation from MDPs in the BM (Varol et al., 2007). BM-resident
Ly6C− cells were found to incorporate BrdU well before the blood Ly6C− monocytes,
though still delayed when compared to BM Ly6C+ monocytes. This suggests that Ly6C−
BM monocytes are generated in the BM, and Ly6C− blood monocytes are generated in the
blood. In line with this notion, MC21 treatment that ablates Ly6C+ blood but not Ly6C+ BM
monocytes did not impair labelling of BM Ly6C− monocytes (Fig. 4C).
Collectively, these data establish that Ly6C+ monocytes are precursors of Ly6C− cells.
Moreover, the limited acquisition of BrdU label in the Ly6C− monocytes supports the earlier
notion based on adoptive transfer experiments (Geissmann et al., 2003) that these cells have
an extended circulation half life as compared to Ly6C+ monocytes. Finally, differential label
acquisition by Ly6C− BM and blood monocytes suggest that these compartments are
established, and in steady state maintained, independent of each other.
Ly6C+ blood monocytes are obligatory precursors of steady state Ly6C− monocytes
Among monocytes, membrane expression of the chemokine receptor CCR2 is restricted to
Ly6C+ cells and a prerequisite for these cells to exit from the BM (Serbina and Pamer, 2006;
Shi et al., 2011). Accordingly, Ly6C+ monocytes are reported to be selectively reduced in
the circulation of CCR2 deficient mice (Serbina and Pamer, 2006). If Ly6C+ blood
monocytes are precursors of Ly6C− monocytes, the impairment of Ly6C+ cell compartment
would be expected to impinge on Ly6C− monocytes. To probe this point more rigorously we
analyzed monocyte subset distributions in a competitive setting by generating mixed
chimeras, with BM isolated from CCR2-proficient (CD45.1) and CCR2-deficient (CD45.2)
Cx3cr1gfp/+ mice. Analysis of the BM of the respective chimeras eight weeks following
irradiation revealed that the two genotypes were equally prevalent amongst MPs and MDPs,
as well as DC precursors (CDPs and pre-DCs) (Fig. 5A, B). BM-resident CCR2 mutant
Ly6C+ monocytes were found to accumulate, presumably as a result of their impaired BM
exit (Serbina and Pamer, 2006), whereas BM-resident mutant Ly6C− monocytes were
moderately dominated by CD45.1+ WT cells (Fig. 5B). As expected from the reported
phenotype of Ccr2−/− mice (Serbina and Pamer, 2006), in the blood Ly6C+Ccr2−/−
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monocytes (CD45.2) were outcompeted by their CD45.1+ WT counterpart (Fig. 5A), but
CCR2 deficiency also compromised the Ly6C− blood monocytes, with mutant cells under-
represented in both compartments (Fig. 5A, B). The competitive disadvantage of both
Ly6C+ and Ly6C− CCR2-deficient monocytes was also evident in the spleen (Fig. 5B),
although it was less pronounced for Ly6C+ cells, which after having entered the splenic pool
might be trapped due to impaired mobilization.
Collectively, this establishes that the generation of Ly6C− CX3CR1hi monocytes in steady
state critically depends on CCR2 proficient Ly6C+ CX3CR1int monocytes as immediate
precursors. Moreover, in order to serve as Ly6C− CX3CR1hi monocyte progeny these cells
have to exit from the BM to the circulation.
Ly6C+ blood monocytes negatively control the life span of Ly6C− monocytes
The fact that Ccr2−/− mice harbour circulating Ly6C− CX3CR1hi monocytes despite their
impaired Ly6C+ monocyte compartment (Qu et al., 2004) seemingly contradicts the notion
that the latter cells require Ly6C+ monocytes as precursors. Indeed analysis of the
frequencies of the two monocyte subsets in Ccr2−/− Cx3cr1gfp mice, confirmed the presence
of a sizable Ly6C− CX3CR1hi monocyte population, albeit drastically reduced as compared
to Ccr2+/+:Cx3cr1gfp littermates (Fig. 6A). Interestingly, Ly6C− blood monocytes of
Ccr2−/− mice had down-modulated their receptors for the macrophage growth factor,
CSF-1, detected with a CD115 antibody (Fig. 6B). One could postulate that in Ccr2−/−
mice, Ly6C−CX3CR1hi monocytes might compensate for the diminished replenishment
from Ly6C+ monocytes by extending their life span.
To directly investigate thispossibility we took advantage of our fate mapping system. A
single 5 mg tamoxifen gavage of Cx3cr1creER:R26-yfp mice induced in their CX3CR1+ cells
the nuclear translocation of Cre recombinase and rearrangement of the YFP reporter locus,
resulting in a discrete label of Ly6C− monocytes peaking by day 4 after gavage (Fig. 6C).
This label disappeared with time, and exponential trendline fitting from day 4 onwards
yielded a calculated steady state half-life of Ly6C− blood monocytes of 2.2 days (r2=0.996).
If this half-live is critically determined by input from CCR2-expressing Ly6C+ monocytes,
then ablation of the latter using the anti-CCR2 regimen should affect it. Indeed, as seen in
Fig. 6C, MC21 treatment resulted in persistence of YFP-labelled Ly6C− monocytes in
tamoxifen-treated Cx3cr1creER:R26-yfp mice extending their half-life from 2.2 days to 11
days (r2=0.992). Once Ly6C+ monocytes were restored, after cessation of MC21 treatment,
Ly6C− cells regained their steady-state half-life and the population hence lost its YFP label.
The depletion of CCR2-expressing Ly6C+ monocytes was associated with a substantial
down-modulation of detectable CD115 (CSF-1 receptor) on the Ly6C− monocytes
reminiscent of the situation in Ccr2−/− mice (Fig. 6B), which was restored following MC21
withdrawal (Fig. 6D). Down-modulation of the CSF-1 receptor from the cell surface could
be a reflection of engagement by its ligand and indeed, administration of recombinant CSF-1
provided direct evidence that this can occur (Fig. 6E). Since myeloid cells themselves
control the circulating availability of CSF-1 (Bartocci et al., 1987; Tushinski et al., 1982)
depletion of CSF-1R expressing Ly6C+ monocytes in Ccr2−/− mice or MC21-treated
animals could potentially alter the availability of the factor. While a blocking antibody
against the receptor causes a substantial increase in circulating CSF-1 (MacDonald et al.
2010), we were not able to detect such an increase in the depleted animals (Supplemental
Fig. 5). Nevertheless, to examine the function of CSF-1 in the extension of the circulation
half-life of Ly6C− monocytes, we tested the impact of CSF-1 receptor neutralization by
using an antibody shown previously to ablate these cells in a time-dependent manner
(MacDonald et al. 2010). Specifically, we co-administered tamoxifen-treated
Cx3cr1creER:R26-yfp mice with the MC21 regimen and CSF1R antibody. Interestingly and
Yona et al. Page 7
Immunity. Author manuscript; available in PMC 2014 January 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
in support of a role of CSF-1 in the phenomenon, this protocol partially prevented the half-
life extension of the YFP-labeled Ly6C− cells following depletion of Ly6C+ monocytes
(Fig. 6F).
DISCUSSION
Here, we have reported a fate mapping analysis of the murine macrophage and monocyte
compartment taking advantage of mice that harbour genes encoding a GFP reporter or Cre
recombinases in their CX3CR1 loci. We have demonstrated that the major tissue
macrophage populations in the liver, spleen, lung and peritoneal cavity are established
prenatally during mouse development, and provided definitive support for the view that in
the healthy adult organism tissue macrophages can be maintained independent of monocyte
input. In addition, we have provided evidence that CX3CR1int Ly6C+ monocytes are in
steady state an obligatory intermediate for the generation of CX3CR1hi Ly6C− monocytes
and via their abundance control the circulation half-life of their progeny.
Recent studies have highlighted the existence of multiple pathways for the generation and
maintenance of distinct mononuclear phagocyte subpopulations in the adult mouse (Ginhoux
et al., 2010; Jakubzick et al., 2008; Varol et al., 2009). Accordingly, classical short-lived
Flt3L-dependent DCs are continuously renewed by on-going haematopoiesis in the BM that
feeds the periphery with dedicated DC precursors (Naik et al., 2007; Onai et al., 2007;
(Birnberg et al., 2008; Karsunky et al., 2003; Naik et al., 2007; Onai et al., 2007; Waskow et
al., 2008). The temporal tissue residence profiles of macrophages have remained less well
defined (Hume, 2006; Hume et al., 2002). Macrophages residing in the murine intestinal
lamina propria are reported to have an estimated half-life of three weeks (Jaensson et al.,
2008). Moreover, using adoptive cell transfers, we and others provided evidence that these
intestinal CX3CR1+ macrophages are continuously replenished from Ly6C+ monocytes
(Bogunovic et al., 2009; Varol et al., 2009). However, the gut mucosa-associated tissue
likely represents an exception, since it is constitutively exposed to the luminal microflora
and its products, which probably cause tonic low-grade inflammation. Other macrophage
populations such as alveolar macrophage’s have been reported to persist for years (Murphy
et al., 2008). Notably however, previous studies on macrophage half-lives have been
confounded by the fact that they involved irradiation regimens, which induce considerable
damage to the tissue analyzed. Clear distinctions between inflammatory monocyte infiltrates
and resident macrophages in these experimental setups might hence have been blurred. This
complication was recently demonstrated in a series of studies that aimed to define the
origins of brain microglia (Ginhoux et al., 2010).
Our comparative analysis of mice carrying a GFP reporter and conditional or constitutive
active Cre recombinase genes in their Cx3cr1 loci, revealed that Kupffer cells, as well as
lung, peritoneal and splenic macrophage’s are established before birth and remain in
adulthood uncoupled from the steady state monocyte pool. Notably, our results are well in
line with the recent demonstration that epidermal Langerhans' cells are derived from
primitive macrophages and fetal liver cells, but that in adulthood this compartment
maintains itself independent from monocyte input (Hoeffel et al., 2012). Congruent with
these data, patients with autosomal dominant and sporadic monocytopenia present with an
unaffected Langerhans' cell compartment (Bigley et al., 2011). What is more, our results are
consistent with the recent evidence of the coexistence of two independent macrophage
lineages in the mouse according to their differential dependence on the transcription factors
PU.1 and c-myb (Schulz et al., 2012).
It is tempting to speculate that the reliance on resident macrophage populations established
before birth represents an important design principle of tissue homeostasis ensuring
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robustness of the steady state. Accordingly, challenges such as injury and pathogen
encounter will result in the recruitment of highly plastic monocytes, which critically, but
transiently (Ajami et al., 2011) contribute to inflammation and its resolution until restoration
of homeostasis. Although our study focuses on the steady state, we have shown that an
inflammatory stimulus can recruit monocytes whose descendants can seemingly integrate
into the resident serosal, peritoneal cavity macrophage compartment. Future studies will
have to address whether these cells become functionally equivalent to the resident cells and
whether this applies also to solid tissues.
Monocytes can be divided into two main subpopulations, defined in the human as CD14hi
CD16+/−, CD14dim CD16hi cells and in the mouse as Ly6C+ CX3CR1int and Ly6C−
CX3CR1hi cells (Geissmann et al., 2003; Palframan et al., 2001). Earlier studies have
provided circumstantial evidence that the monocyte subpopulations of the mouse are a
differentiation series (Sunderkotter et al., 2004; Varol et al., 2007; Yrlid et al., 2006). Here
we have reported the use of a series of complementary non-invasive approaches to
interrogate the steady state contribution of a Ly6C+ monocyte intermediate to the generation
of Ly6C− monocytes. First, we observed distinct temporal requirements for the creation of
the two monocyte subsets with delayed appearance of the YFP reporter label in Ly6C−
monocytes in Cx3cr1Cre:R26-yfp and Cx3cr1creER:R26-yfp mice, as compared to Cx3cr1gfp
mice. Secondly, we have shown that a BrdU pulse label moves with time from Ly6C+
monocytes to Ly6C− monocytes and ablation of the former cells abolishes appearance of the
label in the latter. The data support earlier reports of an exceedingly short circulation half-
life of Ly6C+ monocytes (Liu et al., 2007; Varol et al., 2007), that is with 0.8 days (19
hours) longer than, but comparable to that of short-lived neutrophils (11.4 hours) (Basu et
al., 2002). Finally, we have shown using competitive mixed chimeras that CCR2, which is
critical for the BM exit of Ly6C+ monocytes (Serbina and Pamer, 2006; Shi et al., 2011) is
also required for the generation of Ly6C− monocytes. This strongly suggests that the
majority, if not all blood Ly6C− monocytes are derived from CCR2+ Ly6C+ blood
monocytes in the steady state. (Supplemental Fig. 1).
We have also demonstrated that Ly6C− monocytes are generated independently in situ in the
bone marrow. Thus, Ly6C− BM monocytes acquired the BrdU label well before the Ly6C−
blood monocytes and appearance of the BrdU label was unaffected by the MC21-mediated
ablation of Ly6C+ blood monocytes. Moreover, also the differential dependence of Ly6C−
BM and blood monocytes on CCR2 expression, as well as the resilience of BrdU
incorporation of the latter to the MC21 regimen, suggest that these cells are generated in BM
and blood, respectively. It remains to be shown whether Ly6C− BM monocytes arise like
Ly6C− blood monocytes via a Ly6C+ intermediate or can be generated directly from MDPs,
since the MC21 treatment spares Ly6C+ BM monocytes. The function of Ly6C− blood
monocytes has been proposed to be to patrol and survey endothelial integrity (Auffray et al.,
2007). When cultured in vitro with CSF-1 (M-CSF) or CSF-2 (GM-CSF) both Ly6C+ and
Ly6C− monocytes can differentiate into macrophages and DCs, respectively (Jung,
unpublished observation). However, while Ly6C+ monocytes are established in vivo
precursors of intestinal macrophages, Ly6C− monocytes fail to do so (Varol et al., 2009).
Moreover, reports demonstrating an in vivo potential of these cells to act as resident
mononuclear phagocyte precursors are scarce (Landsman and Jung, 2007; Nahrendorf et al.,
2007). Paradoxically, in humans the supposed functional equivalent, the CD14− CD16+ non-
classical monocytes, is normally much less abundant but increases in response to chronic
inflammatory stimuli (Ziegler-Heitbrock et al., 2010). In light of our present findings we
propose that Ly6C− blood monocytes represent the homeostatic default product of short-
lived Ly6C+ monocytes in the blood that surveys endothelial integrity (Auffray et al., 2007),
as terminally differentiated blood-resident macrophages.
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Our study has revealed that the life span of Ly6C− blood monocytes is affected by the
prevalence of Ly6C+ blood monocytes, their direct precursors. Thus, whereas these cells
display in un-manipulated steady state a half-life of 2 days, the latter is extended to 11 days
when the Ly6C+ precursors are ablated. Prolonged neutralization of the CSF-1 receptor has
been shown to result in the selective loss of Ly6C− blood monocytes (MacDonald et al.,
2010). Conversely, ablation of CD115+ Ly6C+ blood monocytes could result in an increase
of plasma CSF-1 promoting survival of Ly6C− blood monocytes. Interestingly, CD115
levels were found down-modulated on Ly6C− blood monocytes of CCR2−/− mice.
Moreover, expression of CD115 was also reduced in mice in which Ly6C+ blood monocytes
were ablated, but CD115 was rapidly restored upon withdrawal of the MC21 treatment.
Extension of the half-life in response to the MC21 treatment was partially impaired by
concomitant neutralization of the CSF-1 receptor suggesting that limited CSF-1 availability
in the serum is associated with this phenomenon and that Ly6C+ monocytes constitute a sink
for this critical survival factor. Interestingly, CSF-1 has been reported to induce the NOR1
(Pei et al., 2005), an orphan nuclear receptor and member of the steroid thyroid receptor
family, which also comprises Nur77 (Nr4A) that was recently implicated in the control of
Ly6C− monocyte survival (Hanna et al., 2011).
While the exact molecular pathway underlying the regulation remains to be elucidated, our
study establishes that Ly6C+ monocytes are not only obligatory steady state precursors of
Ly6C− monocytes, but also restrict the life span of their otherwise long-lived progeny.
Conversely, the unique ability of Ly6C− monocyte to extend their circulation half-life could
be a mechanism to ensure robust maintenance of a critical Ly6C− population size,
potentially required for efficient surveillance of endothelial integrity (Auffray et al., 2007),
even under conditions when Ly6C+ monocytes are withdrawn from their precursor task to
sites of inflammation.
Collectively, we have provided here a fate mapping study of murine mononuclear
phagocytes, focusing on macrophages and monocytes. Our results highlight the co-existence
of distinct tissue-resident macrophage populations in the mammalian organism, including
cellular compartments that are established during development from primitive macrophages
or fetal liver cells, but remain during health independent from monocyte input. Within the
monocyte compartment, we have established Ly6C+ blood monocytes as obligatory
precursor cells of Ly6C− blood monocytes and reveal that the life span of these cells can be
dynamically regulated to maintain a stable Ly6C− blood monocyte compartment in case of
Ly6C+ blood monocyte shortage. Full appreciation of the monocyte and macrophage
complexity in the mammalian organism will require future studies exploring the existence of
distinctive molecular and functional characteristics of these distinct populations that might
pave the way for rational strategies to manipulate mononuclear phagocytes for therapeutic
purposes.
EXPERIMENTAL PROCEDURES
Mice
The following 6 to 10 week-old mouse strains were used: Cx3cr1gfp/+ mice (Jung et al.,
2000); Pgk-cre mice (Lallemand et al., 1998), Ccr2−/− mice (Boring et al., 1997);
Ccr2−/−:Cx3cr1gfp/+ mice. To analyse recombinase activity of Cx3cr1cre or Cx3cr1creER
mice, these animals were crossed to Rosa-26-yfp (Srinivas et al., 2001) or Rosa-26-rfp
reporter mice (Luche et al., 2007). BM chimeras, animals were lethally irradiated and
reconstituted with donor BM see online experimental procedures for further details. All
mice studied were on C57BL/6 background, maintained under specific pathogen-free
conditions and handled under protocols approved by the Weizmann Institute Animal Care
Committee (IACUC) in accordance with international guidelines.
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Generation of Cx3cr1cre and Cx3cr1creER mice
See online experimental procedures for further details
Tamoxifen treatment
Tamoxifen was administered either orally or administered s.c. See online experimental
procedures for further details.
Isolation of tissue samples
Blood, BM and tissue samples were prepared as described previously (Yona et al., 2010).
Single-cell suspensions were then stained and subsequently analysed by polychromatic flow
cytometry. A detailed description of tissue mononuclear phagocyte isolation and antibody
clones used throughout this study can be found on the supplemental online experimental
procedures.
Isolation of monocytes for adoptive transfers
BM cells were harvested and mononuclear cells enriched by density gradient. Splenic
monocytes were isolated by MACS enrichment using biotinylated anti-CD115 antibody and
streptavidin-coupled magnetic beads (Miltenyi Biotec). Ly6Chi monocytes were identified
as CD11b+ CD115+ and Gr-1+, cells were purified by high-speed cell sorting using a FACS
Aria (Becton-Dickson). Sorted cells were resuspended and injected i.v. into congenic
CD45.1 WT mice. See online experimental procedures for further details.
BrdU pulsing
Mice were treated with 3 injections of 2 mg BrdU (5-bromo-2-deoxyuridine; BD
Pharmingen) i.p. 3 hours apart or a single 2 mg i.p injection. To assess BrdU incorporation,
monocytes were stained, fixed and permeabilized according to the manufacturer's
instructions prior to analysis by flow cytometry. See online experimental procedures for
further details.
Antibody and cytokine treatment
Mice were treated with 150 µl of CCR2 mAb (clone: MC21) conditioned media i.p. To
block CD115, mice were treated CD115 mAb (clone: M279, MacDonald et al. 2010) i.p.
Recombinant M-CSF (PeproTech) (25µg/mouse) was given i.p. See online experimental
procedures for further details.
Histology
Mice were anaesthetized and perfused with 30 ml of PBS, organs were excised and fixed in
para-formaldehyde prior to being imbedded in OCT. Cryostatic sections, were post-fixed
and stained. Analysis by confocal laser scanning microscopy was performed using a Zeiss
LSM510 microscope. Image acquisition was processed with Zeiss LSM Image browser
software. See online experimental procedures for further details.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Reporter gene expression profile of macrophage populations in Cx3cr1gfp/+,
Cx3cr1cre/+:R26-yfp and Tamoxifen-treated Cx3cr1creER/+:R26-yfp mice
(A) Schematic of modified Cx3cr1 loci. The Cx3cr1cre and Cx3cr1creER mice were crossed
to R26-yfp mice, in which irreversible induction of YFP expression is induced upon Cre
recombinase expression and activation, respectively.
(B & C) Flow cytometric analysis of CX3CR1+ (B) and CX3CR1 (C) mononuclear
phagocyte populations of Cx3cr1gfp/+, Cx3cr1cre/+:R26-yfp and Cx3cr1creER/+:R26-yfp
mice. Cx3cr1creER/+:R26-yfp mice were treated for 4 weeks with Tamoxifen prior to
analysis. Results are representative of 6 mice per group.
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Figure 2. Dual origins of macrophages
(A) (i) Flow cytometric and histological analysis of livers obtained from Cx3cr1cre/+:R26-
rfp:Cx3cr1gfp/+ mice. In these mice GFP expression acts as a direct reporter for CX3CR1
expression, while RFP expression is controlled by Cre recombinase. (ii) Analysis of fetal
liver and adult liver and Kupffer cells of Cx3cr1gfp/+ mice.
(B) Flow cytometric analysis of the intestinal lamina propria of DTx-treated Cd11c-dtr mice
that received 7 days earlier a Ly6C+ YFP monocyte graft isolated from tamoxifen-treated
Cx3cr1creER/+:R26-yfp mice. Results are representative of two experiments involving 3 mice
per group.
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(C) Flow cytometric analysis of peritoneal lavages of Cx3cr1creER/+:R26-rfp mice
administered a single tamoxifen gavage (5 mg) one day following an intra-peritoneal
thioglycollate injection. Rightmost graph shows phenotypic shift of monocyte-derived cells
between three weeks and 8 weeks. Results are representative of two independent
experiments involving 3 mice per group.
Yona et al. Page 18
Immunity. Author manuscript; available in PMC 2014 January 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Reporter gene expression profile of mononuclear phagocyte precursors and circulating
monocytes
(A & B) Flow cytometric analysis of different mononuclear phagocyte populations,
precursors (A) and blood monocytes (B) obtained from Cx3cr1gfp/+, Cx3cr1cre/+:R26-yfp
and Cx3cr1creER/+:R26-yfp mice. Cx3cr1creER/+:R26-yfp mice were treated for 4 weeks with
Tamoxifen prior to analysis. Results are representative of 4–6 mice per group.
(C) Bar graph summarizing frequencies of GFP or YFP+ cells in indicated mononuclear
phagocyte populations of Cx3cr1gfp/+, Cx3cr1cre/+:R26-yfp and Cx3cr1creER/+:R26-yfp
mice. Mean ± SEM are performed with n=4–6 mice per group.
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Figure 4. Monocyte subset dynamics
(A & B) Flow cytometric analysis of Ly6C+ and Ly6C− blood monocyte subsets pulsed
three times with 2 mg BrdU 3 hrs apart and monitored over 5 days. (B) Mice were treated
with the anti-CCR2 antibody MC21 and BrdU incorporation by Ly6C− blood monocyte was
analysed.
(C) Analysis of time course of BrdU incorporation of Ly6C+ and Ly6C− monocytes in blood
(red) and BM (blue) following a single 2 mg pulse of BrdU; BrdU incorporation by
monocytes in mice treated with the MC21 antibody (green). Mean ± SEM are performed
with n=3–4 mice per group.
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Figure 5. Impaired BM exit of Ly6C+ blood monocyte affects the Ly6C− cell compartment
(A) Flow cytometric analysis of mixed [Ccr2−/−:Cx3cr1gfp/+ (CD45.2) /
Ccr2+/+:Cx3cr1gfp/+ (CD45.1) > wt] BM chimeras. Distribution of cells within the
mononuclear compartment were analysed for percentage of CD45.2+ cells. Cell definitions
for gating: MP (Lin CD135+ CD115 CD117+) MDP (Lin CD135+ CD115+ CD117+ CDP
(Lin CD135+ CD115+ CD117) PreDC (Lin CD11cint MHCIICD135+ CD172a CX3CR1+)
monocyte (CD11b+ CD115+). Results are representative of 6 analyzed mice.
(B) Analysis of mixed [Ccr2−/−:Cx3cr1gfp/+ (cd45.2) / Ccr2+/+:Cx3cr1gfp/+ (CD45.1) > wt]
BM chimeras. Representative result of two experiments involving 3–5 mice per group.
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Figure 6. Prevalence of Ly6C+ blood monocytes determines the circulation half-life of Ly6C−
blood cells
(A) Analysis of Ly6C+ and Ly6C− blood monocyte subsets of Ccr2+/+ Cx3cr1gfp/+ and
Ccr2−/− Cx3cr1gfp/+ mice. Mean ± SEM are performed with n=4–6 mice per group.
(B) Mean fluorescent intensities of CD115 expression on Ly6C− monocytes analyzed in (A).
Mean ± SEM are performed with n=4–6 mice each.
(C) Flow cytometric analysis of blood of Cx3cr1creER/+:R26-yfp mice treated by tamoxifen
gavage to induce excision of the STOP cassette from R26-YFP loci. Ly6C− blood
monocytes were analysed over a 2 week period for reporter gene expression. Mice were left
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untreated or treated with the CCR2 antibody MC21. Representative result of two
experiments involving 3 mice per group.
(D) Mean fluorescent intensities of CD115 expression on Ly6C− YFP+ monocytes analyzed
in (D). Mean ± SEM are performed with n=3 mice per group.
(E) Mean fluorescent intensities of CD115 expression on Ly6C− monocytes of mice that
received an injection of recombinant CSF-1. Mean ± SEM are performed with n=3 mice
each.
(F) Flow cytometric analysis of blood of tamoxifen treated Cx3cr1creER/+:R26-yfp mice.
Ly6C− blood monocytes were analysed over a 2 week period for reporter gene expression.
Mice were left untreated, treated with the anti-CCR2 antibody, or treated with a combination
of MC21 and anti-CSF-1 R. Table summarizes half-lives of Ly6C− blood monocytes in the
time window from 4 to 10 days, as determined by exponential trendline fitting.
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